Cargando…

Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain

BACKGROUND: The balance of the benefits and risks of long term use of hormone replacement therapy (HRT) have been a matter of debate for decades. In Europe, HRT requires medical prescription and its advertising is only permitted when aimed at health professionals (direct to consumer advertising is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilet-Rosell, Elisa, Martín-Llaguno, Marta, Ruiz-Cantero, María Teresa, Alonso-Coello, Pablo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850342/
https://www.ncbi.nlm.nih.gov/pubmed/20233393
http://dx.doi.org/10.1186/1471-2458-10-134
_version_ 1782179772890087424
author Chilet-Rosell, Elisa
Martín-Llaguno, Marta
Ruiz-Cantero, María Teresa
Alonso-Coello, Pablo
author_facet Chilet-Rosell, Elisa
Martín-Llaguno, Marta
Ruiz-Cantero, María Teresa
Alonso-Coello, Pablo
author_sort Chilet-Rosell, Elisa
collection PubMed
description BACKGROUND: The balance of the benefits and risks of long term use of hormone replacement therapy (HRT) have been a matter of debate for decades. In Europe, HRT requires medical prescription and its advertising is only permitted when aimed at health professionals (direct to consumer advertising is allowed in some non European countries). The objective of this study is to analyse the appropriateness and quality of Internet advertising about HRT in Spain. METHODS: A search was carried out on the Internet (January 2009) using the eight best-selling HRT drugs in Spain. The brand name of each drug was entered into Google's search engine. The web sites appearing on the first page of results and the corresponding companies were analysed using the European Code of Good Practice as the reference point. RESULTS: Five corporate web pages: none of them included bibliographic references or measures to ensure that the advertising was only accessible by health professionals. Regarding non-corporate web pages (n = 27): 41% did not include the company name or address, 44% made no distinction between patient and health professional information, 7% contained bibliographic references, 26% provided unspecific information for the use of HRT for osteoporosis and 19% included menstrual cycle regulation or boosting feminity as an indication. Two online pharmacies sold HRT drugs which could be bought online in Spain, did not include the name or contact details of the registered company, nor did they stipulate the need for a medical prescription or differentiate between patient and health professional information. CONCLUSIONS: Even though pharmaceutical companies have committed themselves to compliance with codes of good practice, deficiencies were observed regarding the identification, information and promotion of HRT medications on their web pages. Unaffected by legislation, non-corporate web pages are an ideal place for indirect HRT advertising, but they often contain misleading information. HRT can be bought online from Spain, without a medical consultation or prescription constituting a serious issue for public health. In our information society, it is the right and obligation of public health bodies to ensure that such information is not misleading.
format Text
id pubmed-2850342
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28503422010-04-07 Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain Chilet-Rosell, Elisa Martín-Llaguno, Marta Ruiz-Cantero, María Teresa Alonso-Coello, Pablo BMC Public Health Correspondence BACKGROUND: The balance of the benefits and risks of long term use of hormone replacement therapy (HRT) have been a matter of debate for decades. In Europe, HRT requires medical prescription and its advertising is only permitted when aimed at health professionals (direct to consumer advertising is allowed in some non European countries). The objective of this study is to analyse the appropriateness and quality of Internet advertising about HRT in Spain. METHODS: A search was carried out on the Internet (January 2009) using the eight best-selling HRT drugs in Spain. The brand name of each drug was entered into Google's search engine. The web sites appearing on the first page of results and the corresponding companies were analysed using the European Code of Good Practice as the reference point. RESULTS: Five corporate web pages: none of them included bibliographic references or measures to ensure that the advertising was only accessible by health professionals. Regarding non-corporate web pages (n = 27): 41% did not include the company name or address, 44% made no distinction between patient and health professional information, 7% contained bibliographic references, 26% provided unspecific information for the use of HRT for osteoporosis and 19% included menstrual cycle regulation or boosting feminity as an indication. Two online pharmacies sold HRT drugs which could be bought online in Spain, did not include the name or contact details of the registered company, nor did they stipulate the need for a medical prescription or differentiate between patient and health professional information. CONCLUSIONS: Even though pharmaceutical companies have committed themselves to compliance with codes of good practice, deficiencies were observed regarding the identification, information and promotion of HRT medications on their web pages. Unaffected by legislation, non-corporate web pages are an ideal place for indirect HRT advertising, but they often contain misleading information. HRT can be bought online from Spain, without a medical consultation or prescription constituting a serious issue for public health. In our information society, it is the right and obligation of public health bodies to ensure that such information is not misleading. BioMed Central 2010-03-16 /pmc/articles/PMC2850342/ /pubmed/20233393 http://dx.doi.org/10.1186/1471-2458-10-134 Text en Copyright ©2010 Chilet-Rosell et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Chilet-Rosell, Elisa
Martín-Llaguno, Marta
Ruiz-Cantero, María Teresa
Alonso-Coello, Pablo
Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain
title Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain
title_full Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain
title_fullStr Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain
title_full_unstemmed Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain
title_short Hormone Replacement Therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain
title_sort hormone replacement therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in spain
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850342/
https://www.ncbi.nlm.nih.gov/pubmed/20233393
http://dx.doi.org/10.1186/1471-2458-10-134
work_keys_str_mv AT chiletrosellelisa hormonereplacementtherapyadvertisingsenseandnonsenseonthewebpagesofthebestsellingpharmaceuticalsinspain
AT martinllagunomarta hormonereplacementtherapyadvertisingsenseandnonsenseonthewebpagesofthebestsellingpharmaceuticalsinspain
AT ruizcanteromariateresa hormonereplacementtherapyadvertisingsenseandnonsenseonthewebpagesofthebestsellingpharmaceuticalsinspain
AT alonsocoellopablo hormonereplacementtherapyadvertisingsenseandnonsenseonthewebpagesofthebestsellingpharmaceuticalsinspain